Skip to main content

Table 3 Patient Demographics

From: Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database

 

Number of Cases (%)*

 

Entire Database

TMA only

Heat map only

Gender

Male

688 (52)

63 (60)

46 (60)

Female

635 (48)

42 (40)

31 (40)

Race

Caucasian

587 (44)

63 (60)

51 (66)

African American

377 (28)

34 (32)

23 (30)

Other

38 (3)

2 (2)

3 (4)

Non-Specified

321 (24)

6 (6)

n/a

Histology

Adenocarcinoma

603 (46)

58 (55)

51 (66)

Large Cell Carcinoma

75 (6)

18 (17)

15 (19)

Squamous Cell Carcinoma

338 (26)

15 (14)

11 (14)

NSCLC Non-Specified

307 (23)

14 (13)

n/a

Stage

I

379 (29)

49 (47)

37 (48)

II

123 (9)

12 (11)

8 (10)

III

261 (20)

32 (30)

27 (35)

IV

173 (13)

6 (6)

5 (6)

Non-Specified

384 (29)

6 (6)

n/a

Vital Status

Alive

537 (41)

32 (30)

24 (31)

Deceased

452 (34)

71 (68)

53 (69)

Unknown

334 (25)

2 (2)

n/a

Mean Age at Diagnosis

64 years

61 years

61 years

Median Survival

17 months

16 months

17 months

Total NSCLC Cases

1323

105

77

  1. *Due to rounding, percentages may not sum to 100.
  2. To date, 1323 NSCLC patients have been captured in the database. A subset of these have TMA data (n = 105) and a further subset of patients were included in the heat map analysis.